ASPI ASP Isotopes Inc.
Price Chart
Executive Summary
ASP Isotopes provided a business update highlighting progress across its nuclear medicine, electronics, and nuclear energy platforms, including expected commercial shipments in 2026, helium production milestones, and a long-term EBITDA target of over $300 million by 2031. The company has $333 million in cash as of December 2025.
Actionable Insight
Traders should monitor the company's progress toward commercial shipments in 2026 and helium production milestones, as well as its ability to achieve the long-term EBITDA target. The significant cash position provides runway but the increasing net loss warrants caution.
Key Facts
- First commercial shipments expected for Ytterbium-176, Carbon-14, and Silicon-28 in 2026
- Helium Phase 1 nameplate capacity expected in Q3 2026
- EBITDA target of greater than $300 million in 2031
- Cash, cash equivalents, and short-term marketable securities of $333 million as of December 31, 2025
- Product revenue for 2025 was $5.7 million, up 46% from $3.9 million in 2024
- Net loss was $175.1 million in 2025, compared to $32.3 million in 2024
Financial Impact
EBITDA target of greater than $300 million by 2031, with $333 million in cash as of December 2025
Risk Factors
- Increasing net loss from $32.3 million in 2024 to $175.1 million in 2025
- Dependence on successful commercialization of new products in 2026
- Execution risk in achieving helium production milestones
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001477932-26-002140 |
| Document: aspi_8k.htm | 0001477932-26-002140 |
| Document: 0001477932-26-002140-index-headers.html | 0001477932-26-002140 |
| Document: 0001477932-26-002140-index.html | 0001477932-26-002140 |
| Document: 0001477932-26-002140.txt | 0001477932-26-002140 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
3d ago
|
Institutional Cluster
| $6.22 awaiting T+1 | awaiting T+1 | — | $6.55 (+5.31%) |
|
Jun 2, 2026
13d ago
|
144
| $8.33 $7.55 | ▼ −9.36% | ▼ −8.64% | $6.55 (−21.37%) |
|
May 26, 2026
19d ago
|
8-K
| $6.93 $6.67 | ▼ −3.75% | ▼ −3.77% | $6.55 (−5.48%) |
|
May 20, 2026
25d ago
|
8-K
| $5.17 $5.55 | ▲ +7.35% | ▲ +6.90% | $6.55 (+26.69%) |
|
May 11, 2026
4w ago
|
8-K
| $6.22 $5.97 | ▼ −4.02% | ▼ −3.88% | $6.55 (+5.31%) |
|
Apr 18, 2026
8w ago
|
144
| $5.47 $5.06 | ▼ −7.50% | ▼ −6.84% | $6.55 (+19.74%) |
|
Apr 13, 2026
8w ago
|
8-K
| $5.06 $5.00 | ▼ −1.19% | ▼ −2.40% | $6.55 (+29.45%) |
|
Apr 10, 2026
9w ago
|
8-K
| $4.48 $5.06 | ▲ +12.95% | ▲ +11.97% | $6.55 (+46.21%) |
|
Mar 24, 2026
11w ago
|
Press Release
| $4.98 $5.04 | ▲ +1.20% | ▲ +0.64% | $6.55 (+31.53%) |
|
Mar 6, 2026
14w ago
|
Press Release
| $5.55 $5.81 | ▲ +4.68% | ▲ +3.84% | $6.55 (+18.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access